These results revearla biochemical pathway whereby a product secreted by virus-transformed cells affects one function of a cell central to the host's immunological defense system. When sensitized lymphocytes are grown in vitro in the presence of specific antigen, they produce a substance known as migration inhibitory factor (MIF), which inhibits the migration of guinea pig peritoneal exudate (GPPE) cells (primarily macrophages) in vitro (1). We have previously reported that culture fluids from simian virus 40 (SV40)-transformed 3T3 cell cultures, but not from untransformed 3T3 cell cultures, also inhibit the migration of GPPE cells (2). In addition, such inhibited GPPE cultures lost a densely staining material from the cell-surface coat (DSM), as also occurs when GPPE cultures are treated with lymphocyte MIF (3). MIF-like activities have previously been shown to be produced by several different nonlymphoid cell lines in vitro (4).
present paper describes the generation of migration inhibitory factor (MIF)like activity for peritoneal exudate cells from guinea pigs after incubation of a serum-free harvest fluid from SV3T3 cells with guinea pig serum. Inhibited macrophages lose a densely staining material from the cell surface coat compared with uninhibited guinea pig peritoneal exudate cells. The factor in SV3T3 harvest fluids which generates the migration inhibitory activity appears to be plasminogen activator, i.e., a serine protease, because (i) These results revearla biochemical pathway whereby a product secreted by virus-transformed cells affects one function of a cell central to the host's immunological defense system. When sensitized lymphocytes are grown in vitro in the presence of specific antigen, they produce a substance known as migration inhibitory factor (MIF), which inhibits the migration of guinea pig peritoneal exudate (GPPE) cells (primarily macrophages) in vitro (1) . We have previously reported that culture fluids from simian virus 40 (SV40)-transformed 3T3 cell cultures, but not from untransformed 3T3 cell cultures, also inhibit the migration of GPPE cells (2) . In addition, such inhibited GPPE cultures lost a densely staining material from the cell-surface coat (DSM), as also occurs when GPPE cultures are treated with lymphocyte MIF (3) . MIF-like activities have previously been shown to be produced by several different nonlymphoid cell lines in vitro (4) .
Recently, our finding that MIF-like activity was produced in SV3T3 cell cultures has been confirmed and considerably Assay of Plasminogen Activator. Plasminogen activator activity was assayed on 125I-labeled fibrin-coated plastic petri dishes (7, 11) in the presence of partially purified FCS plasminogen. The plasminogen was isolated from FCS by one cycle of affinity chromatography on lysine-Sepharose 4B (12) and was determined to be 80% plasminogen by sodium dodecyl sulfate/polyacrylamide gel electrophoresis. Assay mixtures contained 0.1 ml of the G-200 column fraction, FCS plasminogen fractiQn (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) ,ug of protein as bovine serum albumin) and 0.1 M Tris-HC1 buffer, pH 8.1, in a total volume of 1.0 ml. Plates were incubated at 370 for 4 hr and 0.2 ml-aliquots of the supernatant removed for determination of the amount of released 12'I radioactivity. Generation Agents.) This preparation showed several peaks on Coomassie brilliant blue-stained sodium dodecyl sulfate (7.5%)/polyacrylamide gels with estimated molecular weights of 90,000 (minor component), 51,000 and 42,000 (major components), and 33,000 (minor). The 51,000, 42,000, and 33,000 molecular weight components were labeled after reaction with [3H]Dip-F (13), and this suggested that the 42,000 and 33,000 molecular weight components are breakdown products of UK which retain the ability to react with [3H]Dip-F.
Preparation of Guinea Pig Serum. Blood was collected by cardiac puncture from a group of ether-anesthetized Hartley guinea pigs (males) into sterile glass tubes, allowed to clot for 45 min to 2 hr at room temperature, then centrifuged at 300 X g for 10 min at 4°. Aliquots of the resulting serum were stored at -20°until use. Serum was thawed immediately before use and was never refrozen.
RESULTS
Requirements for Generation of MIF-Like Activity. Study of the conditions required for the generation of MIF-like activity in SV3T3 cultures (Table 1) revealed that three factors were necessary. These were (i) a cellular factor which was secreted by the cells when they were cultured in serum-free medium, (ii) serum component(s) supplied by GPS, and (iii) overnight incubation at 37°. Thus, as shown by the data in Table 1 , combination of an SV3T3 HF and guinea pig serum (GPS) plus overnight incubation yielded significant migration inhibition, in contrast to results obtained with HF from 3T3 cells or with unincubated samples.
The morphological aspects of migration inhibition in GPPE cell cultures treated with HF-incubated medium resembled those previously described (2, 3) for cells whose migration was inhibited by medium from SV3T3 cultures. As shown in Fig.  1A , inhibited cells in HF-incubated medium lost the DSM detectable with the osmium potassium ferrocyanide technique (3). Control cells, cultured in SV3T3 HF-medium which had not been incubated, did not show migration inhibition and had a readily detectable DSM (Fig. 1B) . Thus, a morphological correlate of migration inhibition in other systems (2, 3), i.e., the Cell Biology: Roblin et in SV3T3 HF which generates migration inhibition has the same molecular size as SV3T3 cell plasminogen activator. Dip-F Treatment Inactivates Plasminogen Activator Activity and Capacity to Generate MIF-Like Activity. If SV3T3 cell plasminogen activator is responsible for generation of the MIF-like activity of SV3T3 cultures, then inactivation of the plasminogen activator activity would also be expected to inactivate the capacity to generate MIF-like activity. To test this hypothesis, we combined fractions from the Sephadex G-200 column plasminogen activator peak region (Fig. 2 upper) , treated one aliquot with [3H]Dip-F in propylene glycol, while the other aliquot was mock-treated. As shown in Table 3 the low pH/ammonium sulfate precipitation procedure and cochromatograph on a Sephadex G-200 column. The simplest interpretation of these results is that the SV3T3 cell-plasminogen activator generates MIF-like activity upon interaction with a component(s) of guinea pig serum. Our finding that UK, a known plasminogen activator, also generates MIF-like activity upon overnight incubation with GPS (Table 2) is consistent with this interpretation.
Our previous results (2) and data reported here (Table 1) show that untransformed 3T3 cell cultures and HF prepared from such cultures, generally do not yield MIF-like activity under conditions where SV3T3 cell culture medium and SV3T3 HF do so. We suggest that the quantity of plasminogen activator in the HF is the determining factor because the HF from SV3T3 cells assayed in Table 1 , experiment 4, contained eight times more plasminogen activator activity than the 3T3 cell HF in that experiment (data not shown). The observation that generation of MIF-like activity by urokinase is not reproducibly observed until at least 1600 CTA units of UK are used (unpublished data and Table 2) demonstrates that a certain threshold dose of plasminogen activator is required for generation of the MIF-like activity and is consistent with this explaCell Biology: Roblin et A nation of the lack of formation of MIF-like activity by 3T3 cell cultures and HF from 3T3 cells.
Our results indicate that plasminogen activator activity produced by SV3T3 cells can initiate the formation of molecule(s) which inhibit the migration of GPPE cells. The requirement for overnight incubation to generate MIF-like activity indicates that SV3T3 cell plasminogen activator is probably not the migration inhibitory factor (MIF) itself. In addition, the fact that unincubated SV3T3 HF is not inhibitory (Table 1) indicates that migration inhibition is not due solely to depletion of glucose or other nutrients from the medium (14) , despite the fact that SV3T3 HF contains less residual glucose than 3T3 HF (Table 1, footnote) . By adding extra glucose to the SV3T3 HF (Table 1 , experiment 4) to a final concentration of 1 mg/ml before overnight incubation with GPS, we did not significantly reduce the migration inhibitory activity observed in the incubated sample (data not shown).
Addition of SV3T3 cell plasminogen activator or UK to medium containing 15% GPS produces a burst of fibrinolytic activity which decreases progressively over the next several hours, and indicates formation and inactivation of plasmin under such conditions. Thus, formation of the MIF-like activity could be a consequence of direct action of plasminogen activator upon some serum molecule, or generation of the MIF-like activity could be a secondary consequence of the formation of plasmin by plasminogen activator. It is noteworthy, however, that little or no fibrinolytic activity can be detected after overnight incubation of plasminogen activator in 15% GPS medium, at a time when maximal migration inhibitory activity is observed. This suggests that free-plasmin activity is not responsible for migration inhibition, but leaves open the possibility that plasmin formation is an intermediate step in the process of generating the migration-inhibitory molecule(s).
Poste (5) has compared the size and function of SV3T3 cell MIF-like activity and plasminogen activator. Our work cannot be directly compared with that of Poste because he was studying the properties of the active molecule with MIF-like activity while we have provided evidence for the role of plasminogen activator in the initial generation of the active molecule. Plasminogen activator does not appear to be the MIF produced by guinea pig lymphocytes in response to concanavalin A or sensitizing antigen, because antigen activity is not inhibited by Dip-F and does not require overnight incubation for activity (15 Finally, our results suggest a possible explanation for the observation by Cohen et al. (17) that sera from patients with a variety of lymphoproliferative diseases contain a migrationinhibitory activity for GPPE cells. If the tumor cells involved in such malignancies resemble other human tumor cells in secreting high levels of plasminogen activator (8, 9) , then this plasminogen activator secretion might generate MIF-like activity as we have shown here for SV3T3 cell plasminogen activator and UK. Alternatively, the malignant lymphoid cells might be producing an MIF which is independent of plasminogen activator. In any event, the mechanism(s) responsible for the migration inhibitory activity in the sera of certain cancer patients, and the possible effects of such activity on macrophage function and consequent tumor growth appear worthy of further investigation.
